Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Multipotent Adult Progenitor Cells for Immunomodulation Therapy After Liver Transplantation: A Phase I Study of the MiSOT Study Consortium

NCT01841632 is registered in ClinicalTrials.gov with Prof. Dr. Marc-H. Dahlke, Ph. D. as lead sponsor.

NCT NCT01841632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01841632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Multipotent Adult Progenitor Cells for Immunomodulation Therapy After Liver Transplantation: A Phase I Study of the MiSOT Study Consortium
Lead sponsor
Prof. Dr. Marc-H. Dahlke, Ph. D.
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2013
Completion date
December 31, 2016
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation